Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2171 stock hub

HKG/2171 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2171is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.5B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2171

In the news

Latest news · HKG/2171

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E138.9

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-11.2

P25 -14.7P50 2P75 9.4

ROIC-13.8

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2171 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

CNY

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	355
Employees Change	-110%
Employees Change Percent	-23.66
Enterprise value	HKD 11.3B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG1996C1006
Last refreshed	2026-05-10
Market cap	HKD 12.5B
Price	HKD 23.28
Price currency	HKD
Rev Per Employee	393,909.75x
Sector	Healthcare
Sic	2836
Symbol	hkg/2171
Website	https://www.carsgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.87%
EV Earnings	-104.18x
EV/FCF	-42.12x
EV/Sales	81.13x
FCF yield	-2.15%
Forward P/E	138.87x
P/B ratio	14.45x
P/S ratio	89.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-181.36%
EBITDA Margin	-162.27%
Gross margin	63.62%
Gross Profit	HKD 89M
Gross Profit Growth	88.12%
Gross Profit Growth Q	285.22%
Gross Profit Growth3 Y	267.03%
Net Income	HKD -108.9M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-81.89%
Profit Margin	-77.88%
Profit Per Employee	HKD -306,763
ROA	-9.61
Roa5y	-15.71
ROCE	-20.97
ROE	-11.21
Roe5y	-170.6
ROIC	-13.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	43.74%
Cagr3y	23.42%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	218.74x
Revenue Growth Q	125.79x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	170.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.08
Assets	HKD 1.4B
Cash	HKD 1.3B
Current Assets	HKD 1.4B
Current Liabilities	HKD 236.6M
Debt	HKD 68.1M
Debt Equity	HKD 0.08
Debt FCF	HKD -0.25
Equity	HKD 867.3M
Interest Coverage	-33.04
Liabilities	HKD 570.6M
Long Term Assets	HKD 81.3M
Long Term Liabilities	HKD 334.1M
Net Cash	HKD 1.2B
Net Cash By Market Cap	HKD 9.44
Net Cash Growth	-19.06%
Net Debt Equity	HKD -1.36
Tangible Book Value	HKD 870.4M
Tangible Book Value Per Share	HKD 1.62
WACC	5.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.73
Inventory Turnover	6.5
Net Working Capital	HKD -154.5M
Quick ratio	5.65
Working Capital	HKD 1.1B
Working Capital Turnover	HKD 0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	43.7%
200-day SMA	18.32
3Y total return	88.05%
50-day SMA	18.37
50-day SMA vs 200-day SMA	50over200
All Time High	57.25
All Time High Change	-59.34%
All Time High Date	2021-10-04
All Time Low	2.48
All Time Low Change	838.71%
All Time Low Date	2024-09-05
ATR	1.47
Beta	0.28
Beta1y	1.3
Beta2y	1.05
Ch YTD	56.77
High	24.42
High52	28.6
High52 Date	2026-04-20
High52ch	-18.6%
Low	22.4
Low52	10.87
Low52 Date	2026-03-06
Low52ch	114.17%
Ma50ch	26.76%
Price vs 200-day SMA	27.1%
RSI	59.1
RSI Monthly	62.7
RSI Weekly	62.76
Sharpe ratio	0.81x
Sortino ratio	1.44
Total Return	0.15%
Tr YTD	56.77
Tr1m	26.59%
Tr1w	8.38%
Tr3m	64.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -253.6M
Operating margin	-181.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	329,238,915%
Net Borrowing	-117,643,681.3
Shares Insiders	2%
Shares Institutions	11.6%
Shares Out	538,339,999
Shares Qo Q	0.24%
Shares Yo Y	-0.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -297.5M
Average Volume	5,715,439.95x
Bv Per Share	1.62
CAPEX	HKD -5.7M
Ch1m	26.59
Ch1w	8.38
Ch1y	43.7
Ch3m	64.76
Ch3y	88.05
Ch6m	47.44
Change	-2.18%
Change From Open	-3.72
Close	23.8
Days Gap	1.6
Depreciation Amortization	27,625,997.6
Dollar Volume	161,179,080
Earnings Date	2026-03-06
EBIT	HKD -253.6M
EBITDA	HKD -226.9M
EPS	HKD -0.2
F Score	2
FCF	HKD -269.3M
FCF EV Yield	-2.37x
FCF Per Share	HKD -0.5
Financing CF	-124,327,612
Fiscal Year End	December
Founded	2,014
Investing CF	-3,209,345
Is Primary Listing	1
Last Earnings Date	2026-03-06
Last Report Date	2025-12-31
Ma150	17.1
Ma150ch	36.11%
Ma20	22.77
Ma20ch	2.26%
Net CF	-395,764,288
Open	24.18
Position In Range	43.56
Ppne	112,674,686.8
Price Date	2026-05-08
Ptbv Ratio	14.4
Relative Volume	1.26x
Revenue	139,837,961x
SBC By Revenue	20.12x
Share Based Comp	28,136,294
Tr6m	47.44%
Volume	6,923,500
Z Score	0.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2171 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2171 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2171?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.6%

Share of float held by funds and institutions

Insider ownership

+2.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

HKG/2171 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.1

Neutral momentum band

Price vs 200-day MA

+27.1%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2171

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2171 stock rating?

hkg/2171 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2171 analysis?

The full report lives at /stocks/hkg/2171/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2171?

The latest report frames hkg/2171 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2171 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.